Biosimilars: Evidential standards for health technology assessment.
Research output: Contribution to journal › Article › peer-review
Standard Standard
Biosimilars: Evidential standards for health technology assessment. / Hughes, D.; Hughes, D.A.
In: Clinical Pharmacology and Therapeutics, Vol. 87, No. 3, 01.03.2010, p. 257-261.
In: Clinical Pharmacology and Therapeutics, Vol. 87, No. 3, 01.03.2010, p. 257-261.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
Hughes, D & Hughes, DA 2010, 'Biosimilars: Evidential standards for health technology assessment.', Clinical Pharmacology and Therapeutics, vol. 87, no. 3, pp. 257-261. https://doi.org/10.1038/clpt.2009.112
APA
Hughes, D., & Hughes, D. A. (2010). Biosimilars: Evidential standards for health technology assessment. Clinical Pharmacology and Therapeutics, 87(3), 257-261. https://doi.org/10.1038/clpt.2009.112
CBE
Hughes D, Hughes DA. 2010. Biosimilars: Evidential standards for health technology assessment. Clinical Pharmacology and Therapeutics. 87(3):257-261. https://doi.org/10.1038/clpt.2009.112
MLA
Hughes, D. and D.A. Hughes. "Biosimilars: Evidential standards for health technology assessment.". Clinical Pharmacology and Therapeutics. 2010, 87(3). 257-261. https://doi.org/10.1038/clpt.2009.112
VancouverVancouver
Hughes D, Hughes DA. Biosimilars: Evidential standards for health technology assessment. Clinical Pharmacology and Therapeutics. 2010 Mar 1;87(3):257-261. doi: 10.1038/clpt.2009.112
Author
RIS
TY - JOUR
T1 - Biosimilars: Evidential standards for health technology assessment.
AU - Hughes, D.
AU - Hughes, D.A.
PY - 2010/3/1
Y1 - 2010/3/1
U2 - 10.1038/clpt.2009.112
DO - 10.1038/clpt.2009.112
M3 - Article
VL - 87
SP - 257
EP - 261
JO - Clinical Pharmacology and Therapeutics
JF - Clinical Pharmacology and Therapeutics
SN - 0009-9236
IS - 3
ER -